Alt Immunes Pemvidutide Pemvidutide , a novel peptide-based GLP-1/glucagon dual receptor agonist developed by Altimmune, is garnering attention as a potential game-changer in the treatment of obesity and MASH (metabolic dysfunction-associated steatohepatitis)
Both are weekly injections (tirzepatide is also available as a daily ODT)
It is a daily injection, which is a real commitment
With its unique formulation of L-Glutathione, this supplement helps neutralise free radicals, reducing oxidative stress that can lead to premature ageing and various skin concerns
In this form, the vitamin is particularly well tolerated and also suitable for people with a sensitive stomach
Preclinical studies have shown a genetic deletion of antioxidant enzymes (e.g., SOD, GPx) inducing HTN in mice (Rodrigo et al., 2021)